Literature DB >> 1380942

Omission of exon 12 in cystic fibrosis transmembrane conductance regulator (CFTR) gene transcripts.

R Slomski1, M Schloesser, L P Berg, M Wagner, V V Kakkar, D N Cooper, J Reiss.   

Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR) mRNA transcripts isolated from both expressing and "non-expressing" cell types of normal individuals exhibit differential splicing to a variable extent in a region encoding the putative nucleotide binding fold of the CFTR polypeptide. Sequence analysis of the aberrant fragments obtained after cDNA polymerase chain reaction amplification confirmed the in-frame joining of exons 11 and 13. The proportion of alternative splicing is reproducible and constant in a given individual. The omission of exon 12 in a significant proportion of transcripts supports the hypothesis that a minimal amount of correctly expressed CFTR is sufficient for the maintenance of a clinically normal phenotype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380942     DOI: 10.1007/bf00221949

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Worldwide survey of the delta F508 mutation--report from the cystic fibrosis genetic analysis consortium.

Authors: 
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

2.  A child, homozygous for a stop codon in exon 11, shows milder cystic fibrosis symptoms than her heterozygous nephew.

Authors:  H Cuppens; P Marynen; C De Boeck; F De Baets; E Eggermont; H Van den Berghe; J J Cassiman
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

3.  Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis.

Authors:  M Vidaud; P Fanen; J Martin; N Ghanem; S Nicolas; M Goossens
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

4.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

5.  Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; D Bozon; B Kerem; D Markiewicz; P Durie; J M Rommens; L C Tsui
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

6.  Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin.

Authors:  K Yoshimura; H Nakamura; B C Trapnell; C S Chu; W Dalemans; A Pavirani; J P Lecocq; R G Crystal
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

7.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; R Rozmahel; D Bozon; B Kerem; Z Grzelczak; J R Riordan; J Rommens; L C Tsui
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

8.  Effect of deletion of glycoprotein IIb exon 28 on the expression of the platelet glycoprotein IIb/IIIa complex.

Authors:  M A Kolodziej; G Vilaire; S Rifat; M Poncz; J S Bennett
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113

9.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

10.  Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium.

Authors:  C S Chu; B C Trapnell; J J Murtagh; J Moss; W Dalemans; S Jallat; A Mercenier; A Pavirani; J P Lecocq; G R Cutting
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

View more
  6 in total

1.  CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.

Authors:  Molly B Sheridan; Timothy W Hefferon; Nulang Wang; Christian Merlo; Carlos Milla; Drucy Borowitz; Eric D Green; Peter J Mogayzel; Garry R Cutting
Journal:  J Med Genet       Date:  2010-11-20       Impact factor: 6.318

2.  CFTR transcripts are undetectable in lymphocytes and respiratory epithelial cells of a CF patient homozygous for the nonsense mutation R553X.

Authors:  K Will; J Reiss; M Dean; M Schlösser; R Slomski; J Schmidtke; M Stuhrmann
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

3.  Skipping of multiple CFTR exons is not a result of single exon omissions.

Authors:  A Rickers; F Rininsland; L Osborne; J Reiss
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

4.  Reduced splicing efficiency induced by synonymous substitutions may generate a substrate for natural selection of new splicing isoforms: the case of CFTR exon 12.

Authors:  Michela Raponi; Francisco E Baralle; Franco Pagani
Journal:  Nucleic Acids Res       Date:  2006-12-15       Impact factor: 16.971

Review 5.  Estimating the prevalence of functional exonic splice regulatory information.

Authors:  Rosina Savisaar; Laurence D Hurst
Journal:  Hum Genet       Date:  2017-04-12       Impact factor: 4.132

6.  CFTR expression from a BAC carrying the complete human gene and associated regulatory elements.

Authors:  George Kotzamanis; Hassan Abdulrazzak; Jennifer Gifford-Garner; Pei Ling Haussecker; Wing Cheung; Catherine Grillot-Courvalin; Ann Harris; Christos Kittas; Athanasios Kotsinas; Vassilis G Gorgoulis; Clare Huxley
Journal:  J Cell Mol Med       Date:  2008-07-24       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.